9 newer rulings cite the same tariff codes.

Classification can shift over time. Review the more recent rulings below before relying on this one.

N305195 N3 Ruling Active

The tariff classification of Medroxyprogesterone Injection in dosage form, from Italy

Issued August 1, 2019 by U.S. Customs and Border Protection.

Cite this ruling

Copies to clipboard

N3 N305195 (August 1, 2019)

Tariff classification

HTS codes: 3006.60.0000

Headings: 3006

Product description

Medroxyprogesterone Injection is a medicinal preparation containing Medroxyprogesterone Acetate, a derivative of progesterone, as the active ingredient. It is indicated for use, among other things, as a contraceptive and to control uterine bleeding. Medroxyprogesterone Injection will be imported in 150 mg/ml pre-filled syringes and 150 mg/ml vials for injection.

CBP rationale

The applicable subheading for the Medroxyprogesterone Injection in dosage form will be 3006.60.0000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Pharmaceutical goods specified in note 4 to this chapter: Chemical contraceptive preparations based on hormones, on other products of heading 2937 or on spermicides.

Full text

N305195 August 1, 2019 CLA-2-30:OT:RR:NC:N3:138 CATEGORY: Classification TARIFF NO.: 3006.60.0000 Ms. Rhona M. Keeler NorthStar Healthcare 3300 Cork Airport Business Park Kinsale Road, Cork T12 XN72 Ireland RE: The tariff classification of Medroxyprogesterone Injection in dosage form, from Italy Dear Ms. Keeler: In your letter dated July 9, 2019, you requested a tariff classification ruling. Medroxyprogesterone Injection is a medicinal preparation containing Medroxyprogesterone Acetate, a derivative of progesterone, as the active ingredient. It is indicated for use, among other things, as a contraceptive and to control uterine bleeding. Medroxyprogesterone Injection will be imported in 150 mg/ml pre-filled syringes and 150 mg/ml vials for injection. The applicable subheading for the Medroxyprogesterone Injection in dosage form will be 3006.60.0000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Pharmaceutical goods specified in note 4 to this chapter: Chemical contraceptive preparations based on hormones, on other products of heading 2937 or on spermicides.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on the World Wide Web at https://hts.usitc.gov/current. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at [email protected]. Sincerely, Steven A. Mack Director National Commodity Specialist Division

View original on CBP CROSS →

More rulings on the same tariff codes

N349914 July 1, 2025

The tariff classification of Ethinyl Estradiol/Drospirenone Tablets in dosage form, from India

N338063 March 7, 2024

The tariff classification and country of origin of Dr. Reddy’s Azurette® Tablets (Desogestrel and Ethinyl Estradiol Tablets, USP and Ethinyl Estradiol Tablets, USP) in dosage form

N337947 February 26, 2024

The tariff classification and country of origin of Dr. Reddy’s Necon® (Norethindrone and Ethinyl Estradiol Tablets, USP)

N337948 February 23, 2024

The tariff classification and country of origin of Zovia® 1/35 (Ethynodiol Diacetate and Ethinyl Estradiol Tablets, USP) in dosage form

N336875 December 18, 2023

The tariff classification and country of origin of Dr. Reddy’s Tilia FE (Norethindrone Acetate -Ethinyl Estradiol) Tablets in dosage form

N336575 December 12, 2023

The tariff classification and country of origin of Microgestin (Norethindrone Acetate -Ethinyl Estradiol) and Microgestin Fe (Norethindrone Acetate -Ethinyl Estradiol and Ferrous Fumarate) Tablets in dosage form

N334028 August 10, 2023

The tariff classification of the Etonogestrel/Ethinyl Estradiol Vaginal Ring from Spain

N330638 March 1, 2023

The tariff classification of Icosapent Ethyl Capsules in dosage form, from China, and the classification of Norelgestromin and Ethinyl Estradiol Transdermal System from Argentina and India

N328992 November 21, 2022

The tariff classification of New Day (Levonorgestrel) Tablets in dosage form, from Italy

N304655 July 3, 2019

The tariff classification of Levonorgestrel (New Day) Tablets in dosage form, from Germany

Follow N305195

Get an email if this ruling is revoked or modified, or a newer ruling supersedes it.

One email per day at most. Confirm your address once, unsubscribe anytime.

Searching CBP rulings the smart way

Rulings are precedent. See which ones apply to your product: TariffLens semantically searches all 200,000+ CBP rulings and builds defensible classifications backed by ruling citations.